10-HDA from royal jelly ameliorates autism-like behaviors by promoting Treg commitment through microbiota-IL-6-driven bivalent histone remodeling

Autism spectrum disorder is a complex condition that affects how people connect with others and navigate the world, often marked by challenges in social communication and a tendency toward repetitive behaviors. While the exact causes remain a subject of intense study, scientists have increasingly looked at the body's immune system for clues. Specifically, researchers have noticed that in many individuals with autism, there is an imbalance between two types of white blood cells: those that ramp up inflammation and those that calm it down. This imbalance can disrupt the delicate chemical signals in the brain. At the same time, the community of microscopic organisms living in our gut, known as the microbiome, has emerged as a powerful regulator of these immune cells. The question driving this research is whether something as simple as a natural food source could help restore this balance and, in turn, ease the symptoms of autism.

Royal jelly, the nutrient-rich substance fed to queen honeybees, has long been celebrated for its health benefits, but its potential role in treating autism has remained largely unexplored. A team of researchers at Hefei University of Technology set out to investigate this possibility using a well-established mouse model that naturally displays behaviors similar to autism, such as avoiding social interaction and engaging in repetitive actions. They discovered that royal jelly does indeed improve these behaviors, but the secret lies not in the jelly as a whole, but in a specific fatty acid component within it called 10-HDA. This single molecule acts as a master switch, reshaping the gut bacteria, which then signals a reduction in microbiota-derived inflammatory signals, specifically interleukin-6 (IL-6), helping to correct the chemical imbalance in the brain.

The journey of discovery began when the scientists fed royal jelly to the autistic mice for four weeks. The results were clear: the mice became significantly more interested in interacting with other mice and spent less time burying marbles, a common test for repetitive behavior. To find the active ingredient, the researchers separated the royal jelly into its protein and fatty acid parts. Only the fatty acid portion worked, and further testing pinpointed 10-HDA as the sole driver of this improvement. When the mice were given 10-HDA alone, they showed the same positive changes as those fed the full royal jelly, proving that this specific molecule is the key therapeutic agent.

But how does a fatty acid from a bee's diet fix a brain condition? The researchers traced the path from the gut to the brain. They found that 10-HDA changes the composition of the gut bacteria, effectively reorganizing the microbial community. This new bacterial arrangement leads to a suppression of IL-6 produced by the microbiota, which was previously found at high levels in the blood of the autistic mice. This reduction in microbiota-derived IL-6 is critical because it allows the immune system to rebalance. In the mice, the treatment increased the number of regulatory T cells, a type of white blood cell that acts as a peacekeeper, while decreasing the inflammatory cells that were causing trouble.

To confirm that these peacekeeping cells were truly responsible for the behavioral changes, the scientists performed a crucial test. They treated the mice with 10-HDA but simultaneously blocked the production of regulatory T cells. In these mice, the benefits of the treatment vanished; the animals remained socially withdrawn and repetitive. This proved that the expansion of these specific immune cells is not just a side effect but the essential mechanism that allows the behavior to improve. The researchers also identified a unique subset of these cells, which act as a bridge between the inflammatory and calming states, suggesting that 10-HDA helps the immune system find a flexible, healthy middle ground.

The story gets even deeper as the researchers looked at what happens inside the cells themselves. They found that 10-HDA influences the genetic instructions that tell a cell whether to become an inflammatory fighter or a calming peacekeeper. It does this by altering the chemical packaging of DNA, specifically by changing how certain genes are marked. In the presence of 10-HDA, the genes that promote inflammation are effectively silenced, while the genes that support the calming cells are turned on. This process involves a specific enzyme, Kmt2b, which the treatment successfully suppresses, allowing the cells to commit to their new, beneficial role.

This entire chain of events—from a fatty acid in the gut to a change in immune cells and finally to a calmer brain—highlights a profound connection between what we eat, the microbes we host, and our mental health. The study suggests that 10-HDA does not act as a blunt force drug but rather as a precise modulator that guides the body's own systems back toward equilibrium. By restructuring the gut microbiome and lowering microbiota-derived inflammatory signals, the molecule creates an environment where the immune system can naturally correct its own errors. This offers a new perspective on autism, moving beyond the brain to consider the gut and the immune system as vital partners in the condition's development and potential treatment.

The findings provide the first solid evidence that a natural nutrient can mitigate autism-like behaviors by targeting this specific immune pathway. While the research was conducted in mice, the mechanisms uncovered offer a clear roadmap for understanding how nutrition might influence neurodevelopmental conditions in humans. The study does not claim to have found a cure, but it does illuminate a viable path forward, showing that by nurturing the gut and the immune system, it may be possible to ease the core symptoms of autism through the power of targeted nutrition.